Tech Company Financing Transactions

Intersect ENT Funding Round

Norwest Venture Partners, Kleiner Perkins Caufield & Byers and Medtronic participated in a $30 million Series D funding round for Intersect ENT. This VC investment round was announced on 2/25/2013.

Transaction Overview

Company Name
Intersect ENT
Announced On
2/25/2013
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Series D
Investors

Norwest Venture Partners (Lead Investor) (Casper de Clercq)

Kleiner Perkins Caufield & Byers (Dana Mead)

Medtronic

PTV Sciences (Evan Melrose)

U.S. Venture Partners (Casey Tansey)

Proceeds Purpose
The financing will be used to continue the rapid commercial expansion in the United States for the company's PROPEL and PROPEL mini sinus implants and to fund clinical studies of the company's latest product, an office-based treatment for chronic sinusitis sufferers.

Company Information

Company Status
Publicly-held
Industry
Medical Devices & Instruments
Mailing Address
1555 Adams Dr.
Menlo Park, CA 94025
USA
Phone
(650) 641-2100
Website
www.intersectent.com
Email Address
[email protected]
Overview
Intersect ENT's mission is to advance clinically proven therapy solutions that enable ear, nose, and throat (ENT) physicians to solve clinical challenges and improve the quality of life for patients.
Profile
Intersect ENT LinkedIn Company Profile
Social Media
Intersect ENT Company Twitter Account
Company News
Intersect ENT News
Facebook
Intersect ENT on Facebook
YouTube
Intersect ENT on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Thomas West
  Thomas West LinkedIn Profile  Thomas West Twitter Account  Thomas West News  Thomas West on Facebook
Chief Financial Officer
Randy Meier
  Randy Meier LinkedIn Profile  Randy Meier Twitter Account  Randy Meier News  Randy Meier on Facebook
Chief Operating Officer
Christine Kowalski
  Christine Kowalski LinkedIn Profile  Christine Kowalski Twitter Account  Christine Kowalski News  Christine Kowalski on Facebook
VP - General Counsel
David Lehman
  David Lehman LinkedIn Profile  David Lehman Twitter Account  David Lehman News  David Lehman on Facebook
VP - Human Resources
Gwen Carscadden
  Gwen Carscadden LinkedIn Profile  Gwen Carscadden Twitter Account  Gwen Carscadden News  Gwen Carscadden on Facebook
VP - Sales
Robert Binney
  Robert Binney LinkedIn Profile  Robert Binney Twitter Account  Robert Binney News  Robert Binney on Facebook

 

 

Browse more venture capital transactions:

Prev: 2/25/2013: Revance Therapeutics venture capital transaction
Next: 2/25/2013: Cardiovascular Systems venture capital transaction

 

Share this article

 

About Our Venture Capital Transactions Database

We do our best to report on every notable VC transaction. VC investment data records on this site are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.